LymeX Authorization Act — Full text

Section 1. Short title

This Act may be cited as the LymeX Authorization Act.

Section 2. Policy

It is the policy of the United States to—

(1) engage stakeholders, including academia, nonprofits, industry, small business, entrepreneurs, and government to facilitate patient-centered innovations in Lyme disease care;

(2) foster breakthroughs in health education and public awareness initiatives focused on Lyme disease patients; and

(3) accelerate development of next-gen diagnostics that are rapid and patient focused.

Section 3. Authorization of appropriations

There is authorized to be appropriated to the Secretary of Health and Human Services $5,000,000 to carry out prize competitions (as defined in section 24 of the Stevenson-Wydler Technology Innovation Act of 1980 (15 U.S.C. 3719)) to accelerate innovation in the prevention, diagnosis, and treatment of Lyme disease.